The "COSMOS"-Study (Copeptin in Osmoregulation and Stress Assessment)

Completed

Phase N/A Results N/A

Summary of Purpose

Sodium imbalance is common and an adverse prognostic factor in hospitalized patients. However, identifying the causes of sodium imbalance is challenging in clinical practice. Levels of antidiuretic hormone (ADH) are elevated in patients with stroke correlating with disease severity and stress level; however, its measurement is cumbersome. ADH is derived from a larger precursor peptide along with Copeptin, which...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 22 September 2008.

1 Nov 2006 20 Oct 2006 1 Mar 2008 1 Mar 2008 1 Sep 2008 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Probability Sample

Contacts

Not available